Third, inhibition of DNMT1 blocked SHH pathway output as supported by a previous study [62], and pathway inhibition as well as anti-tumor activity were also seen in the presence of genetic alterations within the SHH pathway previously shown to render tumors resistant to SMO inhibition [28]. This evidence concerns the gene SHH and neoplasm.